clindamycin is an approved drug (FDA (1970))
Compound class:
Synthetic organic
Comment: Clindamycin is a semisynthetic lincosamide antibacterial with broad-spectrum activity. The compound also has antimalarial activity.
Clindamycin is one of the key access group antibacterials on the World Health Organization's Model List of Essential Medicines (link provided in the Classification table, under the Summary tab below). The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Classification | |
Compound class | Synthetic organic |
Ligand families/groups | Antimalarial ligands |
Approved drug? | Yes (FDA (1970)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
IUPAC Name |
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide |
International Nonproprietary Names | |
INN number | INN |
2550 | clindamycin |
Database Links | |
Specialist databases | |
Antibiotic DB | Clindamycin |
Other databases | |
CAS Registry No. | 18323-44-9 (source: Scifinder) |
ChEBI | CHEBI:3745 |
ChEMBL Ligand | CHEMBL1753 |
DrugBank Ligand | DB01190 |
DrugCentral Ligand | 678 |
GtoPdb PubChem SID | 404859054 |
PubChem CID | 446598 |
RCSB PDB Ligand | CLY |
Search Google for chemical match using the InChIKey | KDLRVYVGXIQJDK-AWPVFWJPSA-N |
Search Google for chemicals with the same backbone | KDLRVYVGXIQJDK |
Search PubMed clinical trials | clindamycin |
Search PubMed titles | clindamycin |
Search PubMed titles/abstracts | clindamycin |
UniChem Compound Search for chemical match using the InChIKey | KDLRVYVGXIQJDK-AWPVFWJPSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | KDLRVYVGXIQJDK-AWPVFWJPSA-N |
Wikipedia | Clindamycin |